JP2015525349A5 - - Google Patents

Download PDF

Info

Publication number
JP2015525349A5
JP2015525349A5 JP2015516637A JP2015516637A JP2015525349A5 JP 2015525349 A5 JP2015525349 A5 JP 2015525349A5 JP 2015516637 A JP2015516637 A JP 2015516637A JP 2015516637 A JP2015516637 A JP 2015516637A JP 2015525349 A5 JP2015525349 A5 JP 2015525349A5
Authority
JP
Japan
Prior art keywords
stained cells
stained
cells
tumor
density
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015516637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015525349A (ja
JP6449765B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/062405 external-priority patent/WO2013186374A1/en
Publication of JP2015525349A publication Critical patent/JP2015525349A/ja
Publication of JP2015525349A5 publication Critical patent/JP2015525349A5/ja
Application granted granted Critical
Publication of JP6449765B2 publication Critical patent/JP6449765B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015516637A 2012-06-14 2013-06-14 腫瘍組織における免疫細胞を定量するための方法及びその応用 Active JP6449765B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2012/001446 2012-06-14
IB2012001446 2012-06-14
PCT/EP2013/062405 WO2013186374A1 (en) 2012-06-14 2013-06-14 Method for quantifying immune cells in tumoral tissues and its applications

Publications (3)

Publication Number Publication Date
JP2015525349A JP2015525349A (ja) 2015-09-03
JP2015525349A5 true JP2015525349A5 (https=) 2016-07-14
JP6449765B2 JP6449765B2 (ja) 2019-01-09

Family

ID=46881097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015516637A Active JP6449765B2 (ja) 2012-06-14 2013-06-14 腫瘍組織における免疫細胞を定量するための方法及びその応用

Country Status (13)

Country Link
US (1) US10317408B2 (https=)
EP (1) EP2861986B1 (https=)
JP (1) JP6449765B2 (https=)
KR (1) KR102179848B1 (https=)
CN (1) CN104541167B (https=)
AU (1) AU2013276470B2 (https=)
BR (1) BR112014031143B8 (https=)
CA (1) CA2873278C (https=)
DE (1) DE13731071T1 (https=)
ES (1) ES2902879T3 (https=)
IL (1) IL235738B (https=)
SG (1) SG11201408107RA (https=)
WO (1) WO2013186374A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2940115C (en) 2014-02-24 2023-03-14 Ventana Medical Systems, Inc. Methods, kits, and systems for scoring the immune response to cancer by simultaneous detection of cd3, cd8, cd20 and foxp3
WO2016034655A2 (en) * 2014-09-03 2016-03-10 Ventana Medical Systems, Inc. Systems and methods for generating fields of view
US11275080B2 (en) 2014-11-05 2022-03-15 The Regents Of The University Of California Methods for stratifying non-responders to therapies that block PD1/PDL1 axis
CA2973878A1 (en) 2015-01-22 2016-07-28 University Of Massachusetts Cancer immunotherapy
US10705088B2 (en) * 2015-10-23 2020-07-07 Novartis Ag Method of scoring a sample comprising tumor tissue
EP3455631B1 (en) * 2016-05-09 2020-06-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for classifying patients with a solid cancer
EP3889893B1 (en) * 2016-05-18 2022-03-30 F. Hoffmann-La Roche AG Tumor proximity measure
WO2018027223A1 (en) * 2016-08-05 2018-02-08 Duke University Camkk2 inhibitor compositions and methods of using the same
EP3532984B1 (en) * 2016-10-27 2024-05-08 Koninklijke Philips N.V. Apparatus for determining cellular composition information in one or more tissue samples
US11459568B2 (en) 2016-10-31 2022-10-04 University Of Massachusetts Targeting microRNA-101-3p in cancer therapy
CN106846310A (zh) * 2017-01-19 2017-06-13 宁波江丰生物信息技术有限公司 一种基于免疫组化技术的病理辅助分析方法
EP3659110A1 (en) * 2017-07-24 2020-06-03 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in tumor samples
US11814623B2 (en) 2018-01-30 2023-11-14 University Of Massachusetts Methods of treating a wound using epigenetic regulation
ES2965647T3 (es) 2018-01-31 2024-04-16 Ventana Med Syst Inc Procedimientos y sistemas para la evaluación de infiltrado de células inmunitarias en cáncer colorrectal en estadio III
WO2020161125A1 (en) * 2019-02-05 2020-08-13 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer
SG11202112712RA (en) 2019-06-03 2021-12-30 Inst Nat Sante Rech Med Methods for modulating a treatment regimen
WO2021092071A1 (en) 2019-11-07 2021-05-14 Oncxerna Therapeutics, Inc. Classification of tumor microenvironments
CN111551546B (zh) * 2020-06-01 2023-01-03 南京瑟斯检测科技有限公司 一种基于光学微腔结构超材料的免疫组化便捷检测方法
EP4172628A1 (en) * 2020-06-30 2023-05-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapy and radical surgery
US20230235408A1 (en) 2020-06-30 2023-07-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
TWI838687B (zh) * 2021-01-30 2024-04-11 奇美醫療財團法人奇美醫院 評估腫瘤標本免疫狀態的方法
CN113092202A (zh) * 2021-03-25 2021-07-09 上海福君基因生物科技有限公司 一种胃癌预后预测装置
CN113515077A (zh) * 2021-04-23 2021-10-19 重庆德方信息技术有限公司 人体细胞染色过程监控系统及方法
JP2024530213A (ja) 2021-08-10 2024-08-16 ルニット・インコーポレイテッド 病理スライド画像に関する情報を出力する方法及び装置
US20250035635A1 (en) 2022-03-17 2025-01-30 Institut National De La Sante Et De La Recherche Medicale Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
AU2024239150A1 (en) 2023-03-21 2025-10-02 Biograph 55, Inc. Cd19/cd38 multispecific antibodies
CN116646088B (zh) * 2023-07-27 2023-12-01 广东省人民医院 一种预测方法、装置、设备及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69627183T2 (de) * 1995-11-30 2004-01-29 Chromavision Med Sys Inc Verfahren zur automatischen bildanalyse biologischer proben
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
ES2593930T3 (es) * 2005-12-19 2016-12-14 Ventana Medical Systems, Inc. Impresión automatizada de etiquetas para portaobjetos de especímenes de tejido
JP5551702B2 (ja) * 2008-09-16 2014-07-16 ヒストロックス,インコーポレイテッド. バイオマーカー発現の再現性のある定量
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Similar Documents

Publication Publication Date Title
JP2015525349A5 (https=)
DE13731071T1 (de) Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen
Kidman et al. Characteristics of TCR repertoire associated with successful immune checkpoint therapy responses
KR102770415B1 (ko) 항-pd-1/pd-l1에 의해 치료되는 암 환자의 종양-림프구 침윤 및 결과를 모니터링하기 위한 라디오믹스 기반 영상 툴
Kotoula et al. Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials
MX2017001472A (es) Metodo y sistema para obtener informacion geoquimica de pirolisis mediante espectroscopia de descomposicion inducida por laser.
JP2020522697A5 (https=)
Kozlowski et al. An entirely automated method to score DSS-induced colitis in mice by digital image analysis of pathology slides
WO2016145366A8 (en) Systems and methods for serial staining and imaging
Hong et al. A circulating tumor cell cluster-based model for tumor metastasis (Hypothesis)
JP2018511029A5 (https=)
Di Gangi et al. Analytical metabolomics-based approaches to pancreatic cancer
WO2014127267A9 (en) Methods and tools for the diagnosis and prognosis of urogenital cancers
Dou et al. PDCD4 as a predictor of sensitivity to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
JP2014517282A5 (https=)
Jasar et al. Clinicopathological and histomorphological association in K-ras mutated colorectal cancer
US20170045516A1 (en) Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatment
Yao et al. Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases
Kivelä Composition and prognostic significance of T helper lymphocytes in lung cancer
Porsch et al. An automated CT scanner system for quality control
Banzo et al. Resistance to First Line Chemotherapy Treatment in a Patient Diagnosed with Nodular Lymphocyte-predominant Hodgkin Lymphoma Identified by 18F-FDG PET/CT: Diagnostic and Therapeutic Implications
JP2025537743A (ja) がん免疫療法の有効性を予測するための新規バイオマーカー
deMacedo et al. Are Liquid Biopsies Applied Across Every Type of Solid Tumours
Chinnam et al. Immunohistochemical profile of breast carcinomas in correlation with histological gradeexperience of a tertiary care hospital in Andhra Pradesh
JP6763611B2 (ja) アスベスト曝露歴または中皮腫の検査方法